These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35406791)

  • 21. Degradation of relaxin family peptides by insulin-degrading enzyme.
    Bennett RG; Heimann DG; Hamel FG
    Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-Degrading Enzyme: Paradoxes and Possibilities.
    Leissring MA
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.
    Tundo GR; Sbardella D; Oddone F; Grasso G; Marini S; Atzori MG; Santoro AM; Milardi D; Bellia F; Macari G; Graziani G; Polticelli F; Cascio P; Parravano M; Coletta M
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
    Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.
    Durham TB; Toth JL; Klimkowski VJ; Cao JX; Siesky AM; Alexander-Chacko J; Wu GY; Dixon JT; McGee JE; Wang Y; Guo SY; Cavitt RN; Schindler J; Thibodeaux SJ; Calvert NA; Coghlan MJ; Sindelar DK; Christe M; Kiselyov VV; Michael MD; Sloop KW
    J Biol Chem; 2015 Aug; 290(33):20044-59. PubMed ID: 26085101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus.
    Udrisar DP; Wanderley MI; Porto RC; Cardoso CL; Barbosa MC; Camberos MC; Cresto JC
    Exp Biol Med (Maywood); 2005 Jul; 230(7):479-86. PubMed ID: 15985623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes.
    Affholter JA; Hsieh CL; Francke U; Roth RA
    Mol Endocrinol; 1990 Aug; 4(8):1125-35. PubMed ID: 2293021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
    Tundo GR; Sbardella D; Ciaccio C; Grasso G; Gioia M; Coletta A; Polticelli F; Di Pierro D; Milardi D; Van Endert P; Marini S; Coletta M
    Crit Rev Biochem Mol Biol; 2017 Oct; 52(5):554-582. PubMed ID: 28635330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-molecule activators of insulin-degrading enzyme discovered through high-throughput compound screening.
    Cabrol C; Huzarska MA; Dinolfo C; Rodriguez MC; Reinstatler L; Ni J; Yeh LA; Cuny GD; Stein RL; Selkoe DJ; Leissring MA
    PLoS One; 2009; 4(4):e5274. PubMed ID: 19384407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.
    Sbardella D; Tundo GR; Sciandra F; Bozzi M; Gioia M; Ciaccio C; Tarantino U; Brancaccio A; Coletta M; Marini S
    PLoS One; 2015; 10(7):e0132455. PubMed ID: 26186340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
    Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
    Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.
    González-Casimiro CM; Cámara-Torres P; Merino B; Diez-Hermano S; Postigo-Casado T; Leissring MA; Cózar-Castellano I; Perdomo G
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox regulation of insulin degradation by insulin-degrading enzyme.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment.
    Fernández-Díaz CM; Escobar-Curbelo L; López-Acosta JF; Lobatón CD; Moreno A; Sanz-Ortega J; Perdomo G; Cózar-Castellano I
    Histol Histopathol; 2018 Nov; 33(11):1167-1180. PubMed ID: 29726577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
    Fawcett J; Permana PA; Levy JL; Duckworth WC
    Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.
    Rudovich N; Pivovarova O; Fisher E; Fischer-Rosinsky A; Spranger J; Möhlig M; Schulze MB; Boeing H; Pfeiffer AF
    J Mol Med (Berl); 2009 Nov; 87(11):1145-51. PubMed ID: 19809796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Insulin-Degrading Enzyme in Insulin Clearance.
    Leissring MA; González-Casimiro CM; Merino B; Suire CN; Perdomo G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.